April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Different Cell Proliferation Pathways Induced by FGF-2 Through p27 Degradation via ERK1/2 and PI 3-Kinase in Human and Rabbit Corneal Endothelial Cells
Author Affiliations & Notes
  • J. Lee
    Doheny Eye Institute, Los Angeles, California
  • J.-S. Song
    Doheny Eye Institute, Los Angeles, California
    Ophthalmology, University of Southern California, Los Angeles, California
  • R. E. Smith
    Doheny Eye Institute, Los Angeles, California
    Ophthalmology, University of Southern California, Los Angeles, California
  • E. P. Kay
    Doheny Eye Institute, Los Angeles, California
    Ophthalmology, University of Southern California, Los Angeles, California
  • Footnotes
    Commercial Relationships  J. Lee, None; J.-S. Song, None; R.E. Smith, None; E.P. Kay, None.
  • Footnotes
    Support  NIH Grant EY06431 and EY03040, Research to Prevent Blindness Grant
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2834. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Lee, J.-S. Song, R. E. Smith, E. P. Kay; Different Cell Proliferation Pathways Induced by FGF-2 Through p27 Degradation via ERK1/2 and PI 3-Kinase in Human and Rabbit Corneal Endothelial Cells. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2834.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To induce cell proliferation, the cyclin-dependent kinase inhibitor p27Kip1 (p27) must undergo proteolysis through its phosphorylation mechanism. FGF-2 stimulates cell proliferation of rabbit corneal endothelial cells (CECs) by degrading p27. We investigated whether to be induced the cell proliferation pathway and p27 degradation by FGF-2 stimulation in human CECs and compared with those of rabbit CECs.

Methods: : Cell proliferation was measured by MTT assay. Expression of ERK1/2, Akt, and FGF-2 was analyzed by immunoblotting. Phosphorylation of Akt, p27, p38 and ERK1/2 was detected by immunoblotting. Intracellular location of p27 and Ki67 was determined by immunofluorescent staining. Pharmacological inhibitors were used to block PI 3-kinase or ERK1/2.

Results: : FGF-2 dramatically stimulated cell proliferation in human CECs; the effects were completely blocked by pathway specific inhibitors for PI 3-knase and ERK1/2, respectively. We further defined whether FGF-2 induces degradation of p27 through its phosphorylation. Cells maintained in serum-starved medium were stained for p27 in the nuclei, but not for pp27Thr187. However, FGF-2 abolished the staining of p27, while nuclear staining of pp27Thr187 was observed. Using immunoblotting we defined that FGF-2 induced phosphorylation of p27 at Ser10 site. The effects of FGF-2 on p27 expression and phosphorylation of p27 at Thr187 site were completely blocked by LY294002 treatment. We used immunoblotting to define whether both PI 3-kinase and ERK1/2 pathways are independently involved in cell proliferation induced by FGF-2, as observed in rabbit CECs. ERK1/2 activation was completely blocked by treatment of PI 3-kinase inhibitor in response to FGF-2 stimulation; ERK1/2 activation involves cell proliferation induced by FGF-2 as a downstream molecule to PI 3-kinase, which differs from rabbit CECs in which the ERK1/2 pathway is parallel to PI 3-kinase pathway.

Conclusions: : FGF-2 stimulates proliferation of human CECs through PI-3 kinase and its downstream target ERK1/2 pathways, and FGF-2 significantly downregulates p27 through the phosphorylation mechanism.

Keywords: cornea: endothelium • cornea: basic science • signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×